Mr. Muratyan is a lawyer with long-standing experience in the pharmaceutical industry. Over the years, he has held various positions in corporate in-house legal departments. Retired since 2011 from Sanofi, where he was VP-Head of Legal Corporate and Global Compliance Officer, Mr. Muratyan was named in March 2013 member of Eucomed's Compliance Panel;he is also General Secretary of ETHICS (International Society of Healthcare Ethics and Compliance Professionals) and member of the Board of Directors of ICC-France (International Chamber of Commerce-France).

Maija is an Australian qualified lawyer, having a combined LLB/BSC and LLM. Her focus has been on the Life Sciences industry, in which she has held various regional and international roles with both Pfizer and Novartis in Asia Pacific.

In her current role, Maija supports Russia and Asia Pacific for the Alcon Division within the Novartis Group as Associate General Counsel and Country Compliance Officer (for Singapore).

A large part of her work involves providing legal advice and assistance on complex corporate, commercial, BD&L, labour law and compliance matters.

Erinn Hutchinson is a Partner in PwC's Pharmaceutical and Life Sciences Practice, based in Shanghai. Erinn has fifteen years of experience providing business advisory services to pharmaceutical and medical device companies in the areas of compliance , risk management, and performance improvement. Her expertise includes providing comprehensive risk assessment services on a broad range of health care and pharmaceutical operational issues including corporate compliance, monitoring and auditing, corporate integrity agreements, commercial regulations, reimbursement, anti-bribery, and due diligence for mergers and acquisitions. In addition to extensive experience in the U.S. and China, Erinn has performed compliance assessment reviews in Brazil, Croatia, Czech Republic, Denmark, Egypt, France, Germany, Italy, Mexico, Poland, Portugal, Russia, and the Ukraine.

CHEN YANG is a partner in Sidley Austin's Beijing office, where she heads the firm's China Life Sciences practice. Chen's practice focuses on regulatory, corporate and commercial law. She routinely represents international pharmaceutical, medical device and food companies in connection with market entrance, product localization, marketing and promotional activities, product recalls, clinical trials, FCPA/Anti-bribery and other industry-specific regulatory, compliance and enforcement issues, as well as joint ventures, merger and acquisitions, licensing, IP and antitrust matters.

Chen was given the Life Sciences "All-Star" award by The Asian Lawyer, and the highest ranking in the "China/Hong Kong: Corporate/Commercial" category in PLC's Which Lawyer survey of leading Life Science lawyers worldwide.

Sangeet Dalliwall is the APAC Director of Compliance at Carlson Wagonlit Travel based in Singapore. Sangeet is responsible for designing and overseeing all compliance and corporate governance matters in the region. She joined Carlson in 2013 from Rolls-Royce where she led the implementation of the bribery and corruption program globally. Her career has also spanned across risk consultancies as well as the legal sector. She has extensive expertise in legal and compliance matters globally and is experienced in handling the difficulties associated with making headway into unchartered markets and managing regulatory and compliance risks whilst being commercially sensitive.

Shawn McBride is an international business leader and expatriate living in China with nearly 20 years of healthcare experience leading multi-location and multi-cultural businesses. Currently VP/GM of the Direct to Patient and Market Access business at Cardinal Health, he is leading the creation of an innovative online to offline specialty pharmacy network and broader retail channel solutions in greater China. Prior to relocating to China, Shawn was responsible for developing and deploying Cardinal Health's medical device growth strategies for Asia & the European Union. Earlier in his career he held a variety of leadership positions in sales, marketing, sourcing and operational excellence.

Dinesh is an Executive Director with EY based in Mumbai, India. He is part of EY's Fraud Investigation and Dispute Services practice with over 17 years of professional experience. He leads the third party due diligence group at EY India. He has extensive experience in Foreign Corrupt Practices Act (FCPA) and Anti-Money Laundering (AML) compliance programs and managed large number of global and regional contracts for large global corporations.

Maija is an Australian qualified lawyer, having a combined LLB/BSC and LLM. Her focus has been on the Life Sciences industry, in which she has held various regional and international roles with both Pfizer and Novartis in Asia Pacific.

In her current role, Maija supports Russia and Asia Pacific for the Alcon Division within the Novartis Group as Associate General Counsel and Country Compliance Officer (for Singapore).

A large part of her work involves providing legal advice and assistance on complex corporate, commercial, BD&L, labour law and compliance matters.